Logo image of BKSY

BLACKSKY TECHNOLOGY INC (BKSY) Stock Fundamental Analysis

USA - NYSE:BKSY - US09263B2079 - Common Stock

18.52 USD
-1.18 (-5.99%)
Last: 9/16/2025, 3:28:46 PM
Fundamental Rating

3

Overall BKSY gets a fundamental rating of 3 out of 10. We evaluated BKSY against 82 industry peers in the Professional Services industry. The financial health of BKSY is average, but there are quite some concerns on its profitability. While showing a medium growth rate, BKSY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BKSY has reported negative net income.
In the past year BKSY had a positive cash flow from operations.
BKSY had negative earnings in each of the past 5 years.
In the past 5 years BKSY always reported negative operating cash flow.
BKSY Yearly Net Income VS EBIT VS OCF VS FCFBKSY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -27.69%, BKSY is doing worse than 85.37% of the companies in the same industry.
With a Return On Equity value of -99.43%, BKSY is not doing good in the industry: 84.15% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -27.69%
ROE -99.43%
ROIC N/A
ROA(3y)-26.08%
ROA(5y)-34.97%
ROE(3y)-59.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BKSY Yearly ROA, ROE, ROICBKSY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

Looking at the Gross Margin, with a value of 69.08%, BKSY belongs to the top of the industry, outperforming 84.15% of the companies in the same industry.
BKSY's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BKSY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y35.19%
BKSY Yearly Profit, Operating, Gross MarginsBKSY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

4

2. Health

2.1 Basic Checks

BKSY does not have a ROIC to compare to the WACC, probably because it is not profitable.
BKSY has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BKSY has been reduced compared to 5 years ago.
The debt/assets ratio for BKSY is higher compared to a year ago.
BKSY Yearly Shares OutstandingBKSY Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BKSY Yearly Total Debt VS Total AssetsBKSY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -1.08, we must say that BKSY is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.08, BKSY is not doing good in the industry: 84.15% of the companies in the same industry are doing better.
BKSY has a debt to FCF ratio of 61.70. This is a negative value and a sign of low solvency as BKSY would need 61.70 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 61.70, BKSY is doing worse than 68.29% of the companies in the same industry.
BKSY has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.35, BKSY is not doing good in the industry: 78.05% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 61.7
Altman-Z -1.08
ROIC/WACCN/A
WACC7.9%
BKSY Yearly LT Debt VS Equity VS FCFBKSY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.71 indicates that BKSY has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.71, BKSY belongs to the top of the industry, outperforming 91.46% of the companies in the same industry.
BKSY has a Quick Ratio of 3.71. This indicates that BKSY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.71, BKSY belongs to the best of the industry, outperforming 91.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.71
Quick Ratio 3.71
BKSY Yearly Current Assets VS Current LiabilitesBKSY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

BKSY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -121.05%.
The Revenue has decreased by -1.21% in the past year.
BKSY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 49.41% yearly.
EPS 1Y (TTM)-121.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-164.58%
Revenue 1Y (TTM)-1.21%
Revenue growth 3Y44.14%
Revenue growth 5Y49.41%
Sales Q2Q%-10.98%

3.2 Future

BKSY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.77% yearly.
The Revenue is expected to grow by 24.82% on average over the next years. This is a very strong growth
EPS Next Y26.75%
EPS Next 2Y30.54%
EPS Next 3Y25.42%
EPS Next 5Y19.77%
Revenue Next Year9.05%
Revenue Next 2Y20.89%
Revenue Next 3Y23.47%
Revenue Next 5Y24.82%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BKSY Yearly Revenue VS EstimatesBKSY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
BKSY Yearly EPS VS EstimatesBKSY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BKSY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BKSY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKSY Price Earnings VS Forward Price EarningsBKSY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

68.29% of the companies in the same industry are cheaper than BKSY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 330.84
EV/EBITDA N/A
BKSY Per share dataBKSY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as BKSY's earnings are expected to grow with 25.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.54%
EPS Next 3Y25.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BKSY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLACKSKY TECHNOLOGY INC

NYSE:BKSY (9/16/2025, 3:28:46 PM)

18.52

-1.18 (-5.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners45.78%
Inst Owner Change3.74%
Ins Owners2.8%
Ins Owner Change1.07%
Market Cap656.72M
Analysts81.43
Price Target25.63 (38.39%)
Short Float %18.59%
Short Ratio3.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-88.73%
Min EPS beat(2)-186.23%
Max EPS beat(2)8.77%
EPS beat(4)2
Avg EPS beat(4)-98.21%
Min EPS beat(4)-215.64%
Max EPS beat(4)8.77%
EPS beat(8)5
Avg EPS beat(8)-26.26%
EPS beat(12)8
Avg EPS beat(12)-19.91%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-5.82%
Max Revenue beat(2)6.5%
Revenue beat(4)1
Avg Revenue beat(4)-7.97%
Min Revenue beat(4)-19.54%
Max Revenue beat(4)6.5%
Revenue beat(8)2
Avg Revenue beat(8)-2.02%
Revenue beat(12)2
Avg Revenue beat(12)-3.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.79%
PT rev (3m)43.57%
EPS NQ rev (1m)-8.05%
EPS NQ rev (3m)-61.4%
EPS NY rev (1m)-71.56%
EPS NY rev (3m)-67.05%
Revenue NQ rev (1m)-5.38%
Revenue NQ rev (3m)-11.62%
Revenue NY rev (1m)-4.47%
Revenue NY rev (3m)-12.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.27
P/FCF 330.84
P/OCF 34.23
P/B 7.59
P/tB 9.22
EV/EBITDA N/A
EPS(TTM)-3.36
EYN/A
EPS(NY)-0.89
Fwd EYN/A
FCF(TTM)0.06
FCFY0.3%
OCF(TTM)0.54
OCFY2.92%
SpS2.95
BVpS2.44
TBVpS2.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.69%
ROE -99.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.08%
FCFM 1.9%
ROA(3y)-26.08%
ROA(5y)-34.97%
ROE(3y)-59.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y35.19%
F-Score3
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 61.7
Debt/EBITDA N/A
Cap/Depr 47.73%
Cap/Sales 16.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.71
Quick Ratio 3.71
Altman-Z -1.08
F-Score3
WACC7.9%
ROIC/WACCN/A
Cap/Depr(3y)34.25%
Cap/Depr(5y)22.9%
Cap/Sales(3y)16.46%
Cap/Sales(5y)10.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-121.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-164.58%
EPS Next Y26.75%
EPS Next 2Y30.54%
EPS Next 3Y25.42%
EPS Next 5Y19.77%
Revenue 1Y (TTM)-1.21%
Revenue growth 3Y44.14%
Revenue growth 5Y49.41%
Sales Q2Q%-10.98%
Revenue Next Year9.05%
Revenue Next 2Y20.89%
Revenue Next 3Y23.47%
Revenue Next 5Y24.82%
EBIT growth 1Y-2.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year129.51%
EBIT Next 3Y53.62%
EBIT Next 5Y38.8%
FCF growth 1Y104.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y159.39%
OCF growth 3YN/A
OCF growth 5YN/A